Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04436432 · ClinicalTrials.gov registry record
Phenomenology of Anxiety in Preschool Children With ASD
A clinical trial, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.
- Completed
- Registry status
- 75
- Enrollment target
NCT04436432 is a clinical trial that has completed, run by Hugo W. Moser Research Institute at Kennedy Krieger. The registered enrollment target is 75 participants.
The verdict
NCT04436432 has completed, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.
- COMPLETED
- Registry status
- 75 participants
- Enrollment target
Study Summary
This study investigates the prevalence, phenomenology, and correlates of anxiety in preschool children with autism spectrum disorder (ASD) across a two-year period. Attention bias to threat, a potential objective marker of anxiety, also is examined using eye tracking methods.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2018-10-25 |
| Est. Completion | 2021-07-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04436432
The ClinicalTrials.gov registry entry for NCT04436432 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hugo W. Moser Research Institute at Kennedy Krieger, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04436432 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04436432 about?
NCT04436432 is a clinical study titled "Phenomenology of Anxiety in Preschool Children With ASD". This study investigates the prevalence, phenomenology, and correlates of anxiety in preschool children with autism spectrum disorder (ASD) across a two-year period. Attention bias to threat, a potential objective marker of anxiety, also is examined using eye tracking methods.
What is the current status of trial NCT04436432?
This trial is currently completed. The enrollment target is 75 participants. The study started on 2018-10-25. Estimated completion is 2021-07-01.
Who is sponsoring clinical trial NCT04436432?
This trial is sponsored by Hugo W. Moser Research Institute at Kennedy Krieger, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.